OTEZLA XR Trademark

Trademark Overview

On Monday, October 19, 2020, a trademark application was filed for OTEZLA XR with the United States Patent and Trademark Office. The USPTO has given the OTEZLA XR trademark a serial number of 90263407. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 28, 2024. This trademark is owned by Amgen Inc.. The OTEZLA XR trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations for the treatment of chronic inflammatory diseases, ankylosing spondylitis, psoriasis, psoriatic arthritis and cancer
otezla xr

General Information

Serial Number90263407
Word MarkOTEZLA XR
Filing DateMonday, October 19, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 27, 2021

Trademark Statements

Description of MarkThe mark consists of gold and orange diamond shape with a single blue wave piercing the bottom of the diamond. All to the upper left of the word "OTEZLA" in blue and "XR" in orange. The white appearing in the mark represents background or transparent area and is not a part of the mark.
Goods and Servicespharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations for the treatment of chronic inflammatory diseases, ankylosing spondylitis, psoriasis, psoriatic arthritis and cancer
Indication of Colors claimedThe color(s) gold, orange, and blue is/are claimed as a feature of the mark.
NOT AVAILABLE"XR"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 8, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799
Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Trademark Events

Event DateEvent Description
Thursday, October 22, 2020NEW APPLICATION ENTERED
Tuesday, December 8, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 9, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, January 27, 2021ASSIGNED TO EXAMINER
Thursday, January 28, 2021NON-FINAL ACTION WRITTEN
Thursday, January 28, 2021NON-FINAL ACTION E-MAILED
Thursday, January 28, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 16, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 16, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 17, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 22, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 7, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 27, 2021PUBLISHED FOR OPPOSITION
Tuesday, July 27, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 21, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 16, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, February 16, 2022SOU EXTENSION 1 FILED
Wednesday, February 16, 2022SOU EXTENSION 1 GRANTED
Friday, February 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 20, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, September 20, 2022SOU EXTENSION 2 FILED
Tuesday, September 20, 2022SOU EXTENSION 2 GRANTED
Thursday, September 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 13, 2023SOU TEAS EXTENSION RECEIVED
Monday, March 13, 2023SOU EXTENSION 3 FILED
Monday, March 13, 2023SOU EXTENSION 3 GRANTED
Wednesday, March 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 6, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, September 6, 2023SOU EXTENSION 4 FILED
Wednesday, September 6, 2023SOU EXTENSION 4 GRANTED
Friday, September 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 24, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, January 24, 2024SOU EXTENSION 5 FILED
Wednesday, February 7, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 7, 2024SOU EXTENSION 5 GRANTED
Thursday, February 8, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 28, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, October 28, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

otezla preparations pharmaceutical ankylosing diseases spondylitis psoriatic cancer arthritis inflammatory psoriasis